Castleberry RP - Search Results

1

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. Look AT, et al. Among authors: castleberry rp. J Clin Oncol. 1991 Apr;9(4):581-91. doi: 10.1200/JCO.1991.9.4.581. J Clin Oncol. 1991. PMID: 2066755 Clinical Trial.

2

Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.

Bagatell R, Rumcheva P, London WB, Cohn SL, Look AT, Brodeur GM, Frantz C, Joshi V, Thorner P, Rao PV, Castleberry R, Bowman LC. Bagatell R, et al. J Clin Oncol. 2005 Dec 1;23(34):8819-27. doi: 10.1200/JCO.2004.00.2931. J Clin Oncol. 2005. PMID: 16314642 Clinical Trial.

3

Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.

George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT. George RE, et al. Among authors: castleberry rp. J Clin Oncol. 2005 Sep 20;23(27):6466-73. doi: 10.1200/JCO.2005.05.582. Epub 2005 Aug 22. J Clin Oncol. 2005. PMID: 16116152 Clinical Trial.

4

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.

Schneiderman J, London WB, Brodeur GM, Castleberry RP, Look AT, Cohn SL. Schneiderman J, et al. Among authors: castleberry rp. J Clin Oncol. 2008 Feb 20;26(6):913-8. doi: 10.1200/JCO.2007.13.9493. J Clin Oncol. 2008. PMID: 18281664

5

Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study.

Shuster JJ, McWilliams NB, Castleberry R, Nitschke R, Smith EI, Altshuler G, Kun L, Brodeur G, Joshi V, Vietti T, et al. Shuster JJ, et al. Am J Clin Oncol. 1992 Aug;15(4):295-303. doi: 10.1097/00000421-199208000-00004. Am J Clin Oncol. 1992. PMID: 1514525

6

Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.

Nitschke R, Smith EI, Altshuler G, Altmiller D, Shuster J, Green A, Castleberry R, Hayes FA, Golembe B, Ducos R. Nitschke R, et al. J Clin Oncol. 1991 Jul;9(7):1181-8. doi: 10.1200/JCO.1991.9.7.1181. J Clin Oncol. 1991. PMID: 2045858

7

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.

Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI, Look AT, Rowe ST, Nash MB, Holbrook T, Alvarado C, Rao PV, Castleberry RP, Cohn SL. Katzenstein HM, et al. Among authors: castleberry rp. J Clin Oncol. 1998 Jun;16(6):2007-17. doi: 10.1200/JCO.1998.16.6.2007. J Clin Oncol. 1998. PMID: 9626197

8

Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.

Mathew P, Valentine MB, Bowman LC, Rowe ST, Nash MB, Valentine VA, Cohn SL, Castleberry RP, Brodeur GM, Look AT. Mathew P, et al. Among authors: castleberry rp. Neoplasia. 2001 Mar-Apr;3(2):105-9. doi: 10.1038/sj.neo.7900146. Neoplasia. 2001. PMID: 11420745 Free PMC article.

9

Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.

London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL. London WB, et al. Among authors: castleberry rp. J Clin Oncol. 2005 Sep 20;23(27):6459-65. doi: 10.1200/JCO.2005.05.571. Epub 2005 Aug 22. J Clin Oncol. 2005. PMID: 16116153

10

Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group study.

Castleberry RP, Shuster JJ, Altshuler G, Smith EI, Nitschke R, Winick N, McWilliams N, Joshi V, Hayes FA. Castleberry RP, et al. J Clin Oncol. 1992 Aug;10(8):1299-304. doi: 10.1200/JCO.1992.10.8.1299. J Clin Oncol. 1992. PMID: 1634920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page